In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Hims & Hers Health Inc (NYSE: HIMS) closed at $29.14 down -8.71% from its previous closing price of $31.92. In other words, the price has decreased by -$8.71 from its previous closing price. On the day, 20.85 million shares were traded. HIMS stock price reached its highest trading level at $31.8899 during the session, while it also had its lowest trading level at $28.9.
Ratios:
For a deeper understanding of Hims & Hers Health Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 21.56 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 32.64. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.79. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on February 18, 2025, Downgraded its rating to Equal-Weight and sets its target price to $60 from $42 previously.
On January 10, 2025, Citigroup Downgraded its rating to Sell which previously was Neutral and also upped its target price recommendation from $24 to $25.
On January 07, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on January 07, 2025, with a $35 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 26 ’25 when Baird Melissa sold 67,687 shares for $34.84 per share. The transaction valued at 2,358,145 led to the insider holds 751,243 shares of the business.
Melissa Baird bought 67,687 shares of HIMS for $2,258,038 on Mar 26 ’25. On Mar 21 ’25, another insider, Okupe Oluyemi, who serves as the Chief Financial Officer of the company, sold 23,118 shares for $32.41 each. As a result, the insider received 749,176 and left with 129,248 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 6473916928 and an Enterprise Value of 6184998912. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 54.49, and their Forward P/E ratio for the next fiscal year is 33.88. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.75. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.38 while its Price-to-Book (P/B) ratio in mrq is 13.50. Its current Enterprise Value per Revenue stands at 4.189 whereas that against EBITDA is 74.443.
Stock Price History:
The Beta on a monthly basis for HIMS is 1.62, which has changed by 0.8607918 over the last 52 weeks, in comparison to a change of 0.06429911 over the same period for the S&P500. Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is -25.73%, while the 200-Day Moving Average is calculated to be 11.54%.
Shares Statistics:
For the past three months, HIMS has traded an average of 22.04M shares per day and 21401380 over the past ten days. A total of 212.46M shares are outstanding, with a floating share count of 181.99M. Insiders hold about 18.08% of the company’s shares, while institutions hold 73.61% stake in the company. Shares short for HIMS as of 1741910400 were 54733233 with a Short Ratio of 2.48, compared to 1739491200 on 46122316. Therefore, it implies a Short% of Shares Outstanding of 54733233 and a Short% of Float of 28.000000000000004.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
